Enzymes in Metabolic Anticancer Therapy
- 4 September 2019
- book chapter
- Published by Springer Nature
- Vol. 1148, 173-199
Abstract
Cancer treatment has greatly improved over the last 50 years, but it remains challenging in several cases. Useful therapeutic targets are normally unique peculiarities of cancer cells that distinguish them from normal cells and that can be tackled with appropriate drugs. It is now known that cell metabolism is rewired during tumorigenesis and metastasis as a consequence of oncogene activation and oncosuppressors inactivation, leading to a new cellular homeostasis typically directed towards anabolism. Because of these modifications, cells can become strongly or absolutely dependent on specific substrates, like sugars, lipids or amino acids. Cancer addictions are a relevant target for therapy, as removal of an essential substrate can lead to their selective cell-cycle arrest or even to cell death, leaving normal cells untouched. Enzymes can act as powerful agents in this respect, as demonstrated by asparaginase, which has been included in the treatment of Acute Lymphoblastic Leukemia for half a century. In this review, a short outline of cancer addictions will be provided, focusing on the main cancer amino acid dependencies described so far. Therapeutic enzymes which have been already experimented at the clinical level will be discussed, along with novel potential candidates that we propose as new promising molecules. The intrinsic limitations of their present molecular forms, along with molecular engineering solutions to explore, will also be presented.Keywords
This publication has 153 references indexed in Scilit:
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Strategies for optimizing the serum persistence of engineered human arginase I for cancer therapyJournal of Controlled Release, 2012
- Functional genomics reveal that the serine synthesis pathway is essential in breast cancerNature, 2011
- Tyrosine aminotransferase: biochemical and structural properties and molecular dynamics simulationsProtein & Cell, 2010
- Glutamine addiction: a new therapeutic target in cancerTrends in Biochemical Sciences, 2010
- Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008International Journal of Cancer, 2010
- The GCN2‐ATF4 pathway is critical for tumour cell survival and proliferation in response to nutrient deprivationThe EMBO Journal, 2010
- The Human Asparaginase-like Protein 1 hASRGL1 Is an Ntn Hydrolase with β-Aspartyl Peptidase ActivityBiochemistry, 2009
- c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolismNature, 2009
- Functional and Structural Characterization of Four Glutaminases from Escherichia coli and Bacillus subtilisBiochemistry, 2008